which has seen the arrival of a new generation of drugs that tackle the skin condition by blocking specific proteins that cause inflammation. Galderma’s drug inhibits the signaling of a protein ...

Reached clearance or almost-clearance of skin lesions, when assessed using the investigator's global assessment (score of 0 or 1 and a ≥2-point improvement from baseline), compared to the placebo ...

Prurigo nodularis is a serious skin condition characterized by several debilitating symptoms, including chronic itch, skin nodules covering large body areas, and poor sleep quality. 5-7,10 ...

Users of weight-loss drugs are seeking help from dermatologists to rectify ‘facial sagging’ after shedding the pounds ...

Dermatology specialist Galderma has claimed a second FDA approval ... which was approved by the FDA in the summer for the rare skin disorder prurigo nodularis – can now be used in the US to ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that the Committee ... 14 Atopic dermatitis is a common, chronic, and flaring inflammatory skin disease which affects approximately ...

we are advancing dermatology for every skin story. For more information: www.galderma.com. 1. Ständer S, et al. Nemolizumab in Patients with Moderate-to-Severe Prurigo Nodularis: A Randomized ...

we are advancing dermatology for every skin story. For more information: www.galderma.com Disclaimer This announcement does not constitute an offer to sell, a solicitation of an offer to buy any ...